## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -3.4% below STRENGTH zone (3.0-6.0%); PEG 3.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-8.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.99)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Reassessing Eastman Chemical (EMN) After a Recent Bounce: Is the Stock Undervalued?**
- Source: Simply Wall Street | 20251221T120810 | Somewhat-Bullish | Relevance: 100%
- Eastman Chemical (EMN) has seen a recent 6.77% bounce, but remains down 28.20% year-to-date and in negative territory over five years. Despite this, the stock appears undervalued with a narrative fair value of $72.76 compared to its recent closing price of $63.56, suggesting potential for a turnaround driven by cost reductions and strategic optimization. Investors should consider the risks, such as trade tensions and uptake of recycled materials, which could delay margin expansion.

**2. Reassessing Eastman Chemical (EMN) After a Recent Bounce: Is the Stock Undervalued?**
- Source: Sahm | 20251221T190804 | Somewhat-Bullish | Relevance: 100%
- Eastman Chemical (EMN) has seen a recent bounce, but its year-to-date and five-year returns are still negative, leading to questions about its valuation. Despite modest earnings growth and a lagging share price, the stock appears cheap on several valuation metrics, suggesting it might be undervalued. However, potential delays in margin expansion due to trade tensions or slow adoption of recycled materials could keep its valuation discount intact.

**3. Reassessing Eastman Chemical (EMN) After a Recent Bounce: Is the Stock Undervalued?**
- Source: Simply Wall Street | 20251221T120857 | Somewhat-Bullish | Relevance: 99%
- Eastman Chemical (EMN) has seen a recent 6.77% bounce, though its year-to-date performance is still down 28.20%. Despite the stock lagging, cost reduction initiatives and strategic optimization could lead to improved margins and a potential fair value of $72.76, suggesting it might be undervalued. However, factors like trade tensions and slower adoption of recycled materials could impact this outlook.

**4. unimaginative title**
- Source: openPR.com | 20251223T080802 | Somewhat-Bullish | Relevance: 97%
- This report by Worldwide Market Reports analyzes the THEIC market, projecting substantial growth in the coming years. It provides a comprehensive overview including market dynamics, competitive analysis, regional insights, and growth opportunities. The study covers key players like BASF and Eastman Chemical Company, segmentation by types and applications, and aims to provide actionable intelligence for business growth.

**5. Goelzer Investment Management Inc. Has $1.29 Million Stake in Eastman Chemical Company $EMN**
- Source: MarketBeat | 20251222T113146 | Neutral | Relevance: 97%
- Goelzer Investment Management Inc. significantly reduced its stake in Eastman Chemical Company by 43.7% in Q3, selling 15,849 shares but retaining a position valued at approximately $1.29 million. Other institutional investors like Vanguard Group Inc. and Invesco Ltd. increased their stakes. Eastman Chemical missed Q3 earnings estimates, but the company recently increased its quarterly dividend to $0.84 and provided FY2025 EPS guidance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $70 | $70 | 0% |
| 2025-12-18 | Citigroup | $72 | $70 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | down | Equal-Weight |
| 2025-12-18 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-8.5% 5d) with bearish MACD, trend may be turning.
2. Valuation risk: PEG 3.8x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 12.7% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.81 signals overvaluation risk, limited margin of safety. Forward P/E 10.2x attractive for 13% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.2B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.81 |
| Forward P/E | 10.2 |
| Current P/E | 11.5 |
| YoY Growth | 13.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.1% to -3.4% (-8.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.3pp (needs >3.0% for momentum thesis). Underperforming sector by 5.2pp, stock-specific weakness. Below SMA200 (0.87x), long-term trend not supportive. RSI neutral at 50. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.35% (CS: 14) | Weak |
| RSI_14 | 50.5 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 0.873x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $62.51
- **Stop Loss:** $58.99 (5.6% risk)
- **Target:** $66.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 255
- **Position Value:** $15,940.05
- **Portfolio %:** 15.94%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*